Scinovex
article Open AccessTop 1% cited

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT<sub>3</sub> receptor antagonist

Alimentary Pharmacology & Therapeutics · 1999 · Vol. 13(9) · pp. 1149–1159
CamilleriMayerDrossmanHeathDukesDavid McSorleyKongAllen W. MangelNorthcutt

Abstract

In female irritable bowel syndrome patients with predominant diarrhoea or alternating constipation and diarrhoea, alosetron is effective in treatment of abdominal pain and discomfort and bowel-related symptoms.

Gastrointestinal motility and disordersMusic Therapy and HealthDiet and metabolism studiesMedicineIrritable bowel syndromePlaceboConstipationInternal medicineGastroenterologyAbdominal painDefecationPathology

MeSH terms

AdultCanadaCarbolinesColonic Diseases, FunctionalDiarrheaDose-Response Relationship, DrugDouble-Blind MethodFemaleGermanyUnited KingdomHumansMaleMiddle AgedNetherlandsSerotonin Antagonists
Citations
372
FWCI
15.10
field-weighted impact
References
36
Percentile
100%
vs. same field & year
Citations per year
References
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
JNCI Journal of the National Cancer Institute · 1959 · 14,848 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT<sub>3</sub> receptor antagonist · Scinovex